Diagnostics · 2020 · 45 citations · 28 references
We have developed a lateral flow immunoassay (LFIA), named NG-Test CTX-M MULTI (NG-Test), to detect group 1, 2, 8, 9, 25 CTX-M producers from agar plates and from positive blood cultures in less than 15 min. The NG-Test was validated retrospectively on 113 well-characterized enterobacterial isolates, prospectively on 102 consecutively isolated ESBL-producers from the Bicêtre hospital and on 100 consecutive blood cultures positive with a gram-negative bacilli (GNB). The NG-Test was able to detect all CTX-M producers grown on the different agar plates used in clinical microbiology laboratories. No false positive nor negative results were observed. Among the 102 consecutive ESBL isolates, three hyper mucous isolates showed an incorrect migration leading to invalid results (no control band). Using an adapted protocol, the results could be validated. The NG-Test detected 99/102 ESBLs as being CTX-Ms. Three SHV producers were not detected. Among the 100 positive blood cultures with GNB tested 10/11 ESBL-producers were detected (8 CTX-M-15, 2 CTX-M-27). One SHV-2-producing-<i>E. cloacae</i> was missed. The NG-Test CTX-M MULTI showed 100% sensitivity and specificity with isolates cultured on agar plates and was able to detect 98% of the ESBL-producers identified in our clinical setting either from colonies or from positive blood cultures.
28
Antibiotic resistance—the need for global solutions
Ramanan Laxminarayan, Adriano Dusé, Chand Wattal et al. · The Lancet Infectious Diseases · 2013 · 4.3K citations · Full text
CTX-M Enzymes: Origin and Diffusion
Rafael Cantón, José María González‐Alba, Juan Carlos Galán · Frontiers in Microbiology · 2012 · 938 citations · Full text
Kim van der Zwaluw, Angela de Haan, Gerlinde Pluister et al. · PLoS ONE · 2015 · 459 citations · Full text
Gram-negative Rods, Carbapenemase Activity, Antimicrobial Susceptibility +13